{"DataElement":{"publicId":"7580324","version":"1","preferredName":"Patient Leukemic Blast Count CD22 Gene Recurrent Disease Gene Expression CD22 Expression Outcome CD22 Gene Gene Expression","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._The determination of the number of leukemic blasts present in a sample._This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia._The return of a disease after a period of remission._Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied._The result of an action._This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia._The process by which a gene gets turned on in a cell to make RNA and proteins. Gene expression may be measured by looking at the RNA, or the protein made from the RNA, or what the protein does in a cell.","longName":"REC_DISEASE_BLAST_EXPRESS_CD22","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7580311","version":"1","preferredName":"Patient Leukemic Blast Count CD22 Gene Recurrent Disease Gene Expression","preferredDefinition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary._The determination of the number of leukemic blasts present in a sample._This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia._The return of a disease after a period of remission._Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","longName":"2233604v1.0:7580309v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2233604","version":"1","preferredName":"Patient","preferredDefinition":"A person who requires medical care.","longName":"C16960","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Patient","conceptCode":"C16960","definition":"A person who receives medical attention, care, or treatment, or who is registered with medical professional or institution with the purpose to receive medical care when necessary.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D847-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7580309","version":"1","preferredName":"Leukemic Blast Count CD22 Gene Recurrent Disease Gene Expression","preferredDefinition":"The determination of the number of leukemic blasts present in a sample.:This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.:The return of a disease after a period of remission.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","longName":"C74630:C20990:C38155:C16608","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leukemic Blast Count","conceptCode":"C74630","definition":"The determination of the number of leukemic blasts present in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"CD22 Gene","conceptCode":"C20990","definition":"This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Recurrent Disease","conceptCode":"C38155","definition":"The return of a disease after a period of remission.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB7CAC59-1B37-7608-E053-4EBD850A7390","latestVersionIndicator":"Yes","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ONEDATA","dateModified":"2021-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB7CAC59-1B48-7608-E053-4EBD850A7390","latestVersionIndicator":"Yes","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ARCHERJ","dateModified":"2021-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7580316","version":"1","preferredName":"CD22 Expression Outcome CD22 Gene Gene Expression","preferredDefinition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied._The result of an action._This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia._The process by which a gene gets turned on in a cell to make RNA and proteins. Gene expression may be measured by looking at the RNA, or the protein made from the RNA, or what the protein does in a cell.","longName":"7580316v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"No, expression on < 20% of blasts","valueDescription":"gene_expr_blasts_20less","ValueMeaning":{"publicId":"7580317","version":"1","preferredName":"gene_expr_blasts_20less","longName":"7580317","preferredDefinition":"Gene expression on less than 20% of blasts","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB7D02A6-851A-75F3-E053-4EBD850A0A8C","latestVersionIndicator":"Yes","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ONEDATA","dateModified":"2021-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB7D02A6-8533-75F3-E053-4EBD850A0A8C","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ONEDATA","dateModified":"2021-02-16","deletedIndicator":"No"},{"value":"Yes, partial expression on 20-90% of blasts","valueDescription":"gene_expr_blasts_20to90","ValueMeaning":{"publicId":"7580318","version":"1","preferredName":"gene_expr_blasts_20to90","longName":"7580318","preferredDefinition":"Partial gene expression on 20-90% of blasts","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB7D02A6-853D-75F3-E053-4EBD850A0A8C","latestVersionIndicator":"Yes","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ONEDATA","dateModified":"2021-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB7D02A6-8556-75F3-E053-4EBD850A0A8C","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ONEDATA","dateModified":"2021-02-16","deletedIndicator":"No"},{"value":"Yes, expressed on > 90% of blasts","valueDescription":"gene_expr_blasts_90greater","ValueMeaning":{"publicId":"7580319","version":"1","preferredName":"gene_expr_blasts_90greater","longName":"7580319","preferredDefinition":"Gene expression on > 90% of blasts","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB7D02A6-8560-75F3-E053-4EBD850A0A8C","latestVersionIndicator":"Yes","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ONEDATA","dateModified":"2021-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BB7D02A6-8579-75F3-E053-4EBD850A0A8C","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ONEDATA","dateModified":"2021-02-16","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7580315","version":"1","preferredName":"CD22 Gene Gene Expression","preferredDefinition":"This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.:Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","longName":"C20990:C16608","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CD22 Gene","conceptCode":"C20990","definition":"This gene is involved in mediating the adhesion between B cells and is a molecular marker for B-cell precursor acute lymphocytic leukemia.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Gene Expression","conceptCode":"C16608","definition":"Typically involves transcription of genetically encoded information into an intermediary message (messenger RNA) and subsequent translation into a functional protein.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB7D02A6-84F2-75F3-E053-4EBD850A0A8C","latestVersionIndicator":"Yes","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ONEDATA","dateModified":"2021-02-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB7D02A6-8503-75F3-E053-4EBD850A0A8C","latestVersionIndicator":"Yes","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"ARCHERJ","dateModified":"2021-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"At time of relapse/MRD recurr","type":"Preferred Question Text","description":"At time of relapse/MRD recurrence, did the leukemic blasts express CD22?","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BB7D4C88-918C-42DD-E053-4EBD850A47B9","latestVersionIndicator":"Yes","beginDate":"2021-02-16","endDate":null,"createdBy":"ARCHERJ","dateCreated":"2021-02-16","modifiedBy":"MAESKEB","dateModified":"2021-10-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}